LENZ vs LYB · rev $7.4M vs P/E 21, rev $16.37B
LENZ Therapeutics Inc (LENZ) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
LENZ currently screens at market cap $223.6M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the LENZ and LYB stock pages for the full models.
Not investment advice.